Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis (2013)

  • Authors:
  • USP affiliated authors: BRENTANI, MARIA MITZI - FM ; KATAYAMA, MARIA LUCIA HIRATA - FM ; ROELA, ROSIMEIRE APARECIDA - FM ; FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM
  • USP Schools: FM; FM; FM; FM
  • DOI: 10.1186/1471-2407-13-451
  • Subjects: NEOPLASIAS PANCREÁTICAS (GENÉTICA;CIRURGIA); APOPTOSE; ADENOCARCINOMA; EXPRESSÃO GÊNICA
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: BMC Cancer
    • ISSN: 1471-2407
    • Volume/Número/Paginação/Ano: v. 13, n. 451, p. (online), 2013
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/1471-2407-13-451 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: hybrid
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1186/1471-2407-13-451 (Fonte: Unpaywall API)

    Título do periódico: BMC Cancer

    ISSN: 1471-2407

    • Melhor URL em Acesso Aberto:


    • Outras alternativas de URLs em Acesso Aberto:


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: BMC Cancer

    ISSN: 1471-2407

    Citescore - 2017: 3.49

    SJR - 2017: 1.464

    SNIP - 2017: 1.066


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2423961-10BCSEP 219 2013
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CHILE, Thais; FORTES, Maria Angela Henriques Zanella; CORRÊA-GIANNELLA, Maria Lúcia Cardillo; et al. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis. BMC Cancer, Londres, v. 13, n. 451, p. (online), 2013. Disponível em: < http://www.biomedcentral.com/1471-2407/13/451 > DOI: 10.1186/1471-2407-13-451.
    • APA

      Chile, T., Fortes, M. A. H. Z., Corrêa-Giannella, M. L. C., Brentani, H. P., Maria, D. A., Puga, R. D., et al. (2013). HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis. BMC Cancer, 13( 451), (online). doi:10.1186/1471-2407-13-451
    • NLM

      Chile T, Fortes MAHZ, Corrêa-Giannella MLC, Brentani HP, Maria DA, Puga RD, Paula V de JR de, Kubrusly MS, Novak EM, Bacchella T, Giorgi RR. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis [Internet]. BMC Cancer. 2013 ; 13( 451): (online).Available from: http://www.biomedcentral.com/1471-2407/13/451
    • Vancouver

      Chile T, Fortes MAHZ, Corrêa-Giannella MLC, Brentani HP, Maria DA, Puga RD, Paula V de JR de, Kubrusly MS, Novak EM, Bacchella T, Giorgi RR. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis [Internet]. BMC Cancer. 2013 ; 13( 451): (online).Available from: http://www.biomedcentral.com/1471-2407/13/451

    Referências citadas na obra
    Jemal A, Siegel R, Xu J, Ward E: Cancer statistics. CA Cancer J. Clin. 2010, 60: 277-300. 10.3322/caac.20073.
    Herreros-Villanueva M, Hijona E, Cosme A, Bujanda L: Adjuvant and neoadjuvant treatment in pancreatic cancer. World J Gastroenterol. 2012, 18 (14): 1565-72. 10.3748/wjg.v18.i14.1565.
    Páez D, Labonte MJ, Lenz HJ: Pancreatic cancer: medical management (novel chemotherapeutics). Gastroenterol Clin North Am. 2012, 41 (1): 189-209. 10.1016/j.gtc.2011.12.004.
    Mark M, Rijli FM, Chambon P: Homeobox genes in embryogenesis and pathogenesis. Pediatr Res. 1997, 42 (4): 421-9. 10.1203/00006450-199710000-00001.
    Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR: The pathophysiology of HOX genes and their role in cancer. J Pathol. 2005, 205 (2): 154-71. 10.1002/path.1710.
    Nunes FD, de Almeida FC, Tucci R, de Sousa SC: Homeobox genes: a molecular link between development and cancer. Pesqui Odontol Bras. 2003, 17 (1): 94-8. 10.1590/S1517-74912003000100018.
    Wellik DM: Hox genes and vertebrate axial pattern. Curr Top Dev Biol. 2009, 88: 257-78.
    Duboule D: The vertebrate limb: a model system to study the Hox/HOM gene network during development and evolution. Bioessays. 1992, 14 (6): 375-84. 10.1002/bies.950140606.
    Cillo C, Faiella A, Cantile M, Boncinelli E: Homeobox genes and cancer. Exp Cell Res. 1999, 248 (1): 1-9. 10.1006/excr.1999.4451.
    Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002, 30 (1): 41-7. 10.1038/ng765.
    Pineault N, Abramovich C, Ohta H, Humphries RK: Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol. 2004, 24 (5): 1907-17. 10.1128/MCB.24.5.1907-1917.2004.
    Hong JH, Lee JK, Park JJ, Lee NW, Lee KW, Na JY: Expression pattern of the class I homeobox genes in ovarian carcinoma. J Gynecol Oncol. 2010, 21 (1): 29-37. 10.3802/jgo.2010.21.1.29.
    Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N, Gross KW, Vivanco MM, Wijendran V, Shioda T, Sgroi D, Donahoe PK, Maheswaran S: HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci USA. 2010, 107 (3): 1100-5. 10.1073/pnas.0912710107.
    Gray S, Pandha HS, Michael A, Middleton G, Morgan R: HOX genes in pancreatic development and cancer. JOP. 2011, 12 (3): 216-9.
    Caré A, Silvani A, Meccia E, Mattia G, Stoppacciaro A, Parmiani G, Peschle C, Colombo MP: HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol. 1996, 16 (9): 4842-51.
    Caré A, Silvani A, Meccia E, Mattia G, Peschle C, Colombo MP: Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence. Oncogene. 1998, 16 (25): 3285-9. 10.1038/sj.onc.1201875.
    Carè A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C, Colombo MP: HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res. 2001, 61 (17): 6532-9.
    Bitu CC, Carrera M, Lopes MA, Kowalski LP, Soares FA, Coletta RD: HOXB7 expression is a prognostic factor for oral squamous cell carcinoma. Histopathology. 2012, 60 (4): 662-5. 10.1111/j.1365-2559.2011.04102.x.
    Liao WT, Jiang D, Yuan J, Cui YM, Shi XW, Chen CM, Bian XW, Deng YJ, Ding YQ: HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res. 2011, 17 (11): 3569-78. 10.1158/1078-0432.CCR-10-2533.
    Nguyen Kovochich A, Arensman M, Lay AR, Rao NP, Donahue T, Li X, French SW, Dawson DW: HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma. Cancer. 2013, 119 (3): 529-39. 10.1002/cncr.27725.
    Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3 (7): Research 0034.1-0034.11.
    Andersen CL, Jensen JL, Orntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004, 64 (15): 5245-50. 10.1158/0008-5472.CAN-04-0496.
    Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real- time quantitative PCR and the 22DDCT Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.
    Abe A, Minaguchi T, Ochi H, Onuki M, Okada S, Matsumoto K, Satoh T, Oki A, Yoshikawa H: PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma. Hum Pathol. 2013, 44 (2): 199-207. 10.1016/j.humpath.2012.05.005.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193 (1): 265-75.
    Ferreira AK, Meneguelo R, Pereira A, Mendonça Filho O, Chierice GO, Maria DA: Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study. Anticancer Res. 2012, 32 (1): 95-104.
    Vêncio RZ, Koide T: HTself: self-self based statistical test for low replication microarray studies. DNA Res. 2005, 12 (3): 211-4. 10.1093/dnares/dsi007.
    Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005, 33: W741-8. 10.1093/nar/gki475.
    Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995, 57 (1): 289-300.
    Wang P, Henning SM, Heber D: Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One. 2010, 5 (4): e10202-10.1371/journal.pone.0010202.
    Yunis AA, Arimura GK, Russin DJ: Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer. 1977, 19: 218-235.
    Kyriazis AP, Kyriazis AA, Scarpelli DG, et al: Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics. Am J Pathol. 1982, 106: 250-260.
    Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ: Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 2010, 39 (4): 425-35. 10.1097/MPA.0b013e3181c15963.
    Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringnér M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A: Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 2002, 62 (21): 6240-5.
    Strathdee G, Holyoake TL, Sim A, Parker A, Oscier DG, Melo JV, Meyer S, Eden T, Dickinson AM, Mountford JC, Jorgensen HG, Soutar R, Brown R: Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res. 2007, 13 (17): 5048-55. 10.1158/1078-0432.CCR-07-0919.
    Wang H, Bei L, Shah CA, Horvath E, Eklund EA: HoxA10 influences protein ubiquitination by activating transcription of ARIH2, the gene encoding Triad1. J Biol Chem. 2011, 286 (19): 16832-45. 10.1074/jbc.M110.213975.
    Yu C, Zhang X, Sun G, Guo X, Li H, You Y, Jacobs JL, Gardner K, Yuan D, Xu Z, Du Q, Dai C, Qian Z, Jiang K, Zhu Y, Li QQ, Miao Y: RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells. J Cell Mol Med. 2008, 12 (6A): 2334-49. 10.1111/j.1582-4934.2008.00257.x.
    Réjiba S, Wack S, Aprahamian M, Hajri A: K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment. Cancer Sci. 2007, 98 (7): 1128-36. 10.1111/j.1349-7006.2007.00506.x.